Trajan Wealth LLC Purchases Shares of 72,721 Merck KGaA $MKGAF

Trajan Wealth LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF) in the 2nd quarter, HoldingsChannel reports. The fund acquired 72,721 shares of the company’s stock, valued at approximately $9,345,000.

Other large investors also recently made changes to their positions in the company. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Merck KGaA in the 2nd quarter valued at $942,087,000. Bank of Nova Scotia purchased a new stake in Merck KGaA during the 2nd quarter worth $281,696,000. Danske Bank A S acquired a new stake in Merck KGaA in the 2nd quarter valued at $276,535,000. Cullen Capital Management LLC purchased a new position in Merck KGaA in the second quarter valued at about $259,158,000. Finally, Korea Investment CORP purchased a new position in Merck KGaA in the second quarter valued at about $239,191,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Trading Up 0.1%

Shares of MKGAF opened at $163.45 on Tuesday. The stock’s 50-day moving average is $162.78 and its two-hundred day moving average is $148.59. The stock has a market cap of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.